Interim report
Page 1
Ipca Laboratories Limited Regd . Office : 48 , Kandivli Industrial Estate , Kandivli ( W ) , Mumbai 400 067 CIN : L24239MH1949PLC007837 Tel : +91 22 6647 4444 , E - mail : investors@ipca.com Website : www.ipca.com AUDITED STATEMENT OF STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31 , 2021 Particulars ( Crores ) Year Ended Sr. No. | Revenue from operations || Other Income III Total Income ( I + II ) March 31 , 2021 Audited * Quarter Ended December 31 , 2020 Unaudited March 31,2020 March 31 , 2021 March 31 , 2020 Audited * Audited Audited 1040.92 1315.22 1004.79 5139.16 4367.43 19.91 15.65 1060.83 1330.87 13.30 1018.09 62.24 64.69 5201.40 4432.12 IV Expenses a ) Cost of materials consumed 409.30 377.72 371.06 1555.53 1431.10 b ) Purchases of stock - in - trade 69.93 61.60 50.85 c ) Changes in inventories of finished goods , ( 178.15 ) 28.08 ( 94.97 ) 197.68 ( 170.73 ) 204.65 ( 155.05 ) work - in - progress and stock - in - trade d ) Employee benefits expense 237.80 230.03 227.88 948.84 870.79 ( e ) Finance costs 2.31 1.56 3.47 8.14 15.79 f ) Depreciation and amortisation expense 48.57 47.66 45.38 187.72 178.69 g ) Other expenses 285.40 268.96 257.25 1094.26 1101.18 Total Expenses ( IV ) 875.16 1015.61 860.92 3821.44 3647.15 < < Profit before exceptional items and tax ( III - IV ) 185.67 315.26 157.17 1379.96 784.97 VI Exceptional items VII Profit before tax ( V - VI ) 185.67 315.26 157.17 1379.96 784.97 Vill Tax Expense -Current tax 36.28 55.10 28.18 244.98 137.98 -Short / ( Excess ) provision of earlier years -Deferred tax liability ( asset ) including MAT credit ( 2.09 ) 0.19 1.23 IX Profit for the period from continuing operations ( VII - VIII ) 151.48 259.97 127.76 ( 5.79 ) 1140.77 ( 5.47 ) 652.46 ✗ Other Comprehensive Income A ( i ) Items that will not be reclassified to profit or loss - Actuarial gain / ( loss ) 0.98 0.59 ( 2.64 ) ( 0.19 ) ( 7.21 ) ( ii ) Income tax relating to items that will not be reclassified to profit or loss ( 0.18 ) | ( 0.10 ) 0.45 0.03 1.25 B ( i ) Items that will be reclassified to profit or loss - Exchange difference in translating the financial statement of foreign operation ( 0.18 ) ( 0.19 ) ( 0.62 ) ( 0.36 ) ( 0.60 ) - Gain / ( loss ) on cash flow hedge 0.14 0.30 ( 0.76 ) 0.65 ( 1.47 ) ( ii ) Income tax relating to items that will be reclassified to 0.01 ( 0.02 ) 0.24 ( 0.05 ) 0.36 profit or loss Other Comprehensive Income / ( Loss ) for the period net of tax ( X ) 0.77 0.58 xxūwww XI Total Comprehensive Income for the period ( IX + X ) 152.25 260.55 ( 3.33 ) 124.43 0.08 1140.85 ( 7.67 ) 644.79 XII Paid - up equity share capital ( Face value of 2 / - each ) XIII Other Equity XIV Share Warrant XV Net Worth XVI Earnings per share ( of 2 / - each ) ( Not annualised ) : Basic ( * ) Diluted ( ) 25.37 25.37 25.27 25.37 4727.35 4752.72 25.27 3640.33 11.94 3677.54 11.94 20.49 10.11 90.08 51,64 11.94 20.49 10.10 90.08 51.60 aboratories Арса * Limited